| Autor: |
Carvalho MO; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil., Duque AP; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil., Huguenin GVB; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.; Nutrition and Dietetics Department, Fluminense Federal University, Niterói 24020-140, RJ, Brazil., Felix Mediano MF; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil., Rodrigues Júnior LF; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.; Department of Physiological Sciences, Federal University of the State of Rio de Janeiro, Rio de Janeiro 20211-010, RJ, Brazil. |
| Abstrakt: |
Background: The coexistence of obesity and low muscle strength-denoted dynapenic obesity (DO)-has been associated with an unhealthy metabolic profile and increased risk for metabolic syndrome. However, there is a lack on studies investigating if DO exhibits higher cardiometabolic risk than non-dynapenic obesity. Objectives: To assess if individuals with DO exhibit elevated cardiometabolic risk compared to non-dynapenic obesity. Methods: a cross-sectional study that analyzed the data of workers from a quaternary care hospital collected between November 2018 and March 2020. Participants were stratified into the following anthropometrical and peripheral muscle strength profiles: non-obese/non-dynapenic (NOND), non-obese/dynapenic (NOD), obese/non-dynapenic (OND), and obese dynapenic (OD). Cardiovascular risk was evaluated by Atherogenic Index (AI), Plasma Atherogenic Index (PAI), Hypertriglyceridemic Waist (HW), A Body Shape Index (ABSI), Atherogenic Dyslipidemia (AD), Castelli Indices I and II, and Framingham Score (FS). Results: the OD group had significantly lower HDL compared to all others ( p = 0.009), and despite exhibited lower prevalence of HW compared to OND ( p < 0.01), a higher cardiometabolic risk compared to OND profile was observed assessing AI ( p = 0.05), Castelli I ( p < 0.05) and Castelli II ( p < 0.05) scores. Conclusions: in the studied population, individuals with DO exhibit elevated cardiometabolic risk compared to other anthropometrical and peripheral muscle strength profiles. |
